Drug intelligence / Profile preview

kou yan qing tablets

Development stage: Unknown
Lead developer: Zhejiang Kangde Pharmaceutical
Administration: Oral

Overview

Kou Yan Qing Tablets is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Zhejiang Kangde Pharmaceutical for the treatment of stomatitis and other oral inflammatory conditions. The product is composed of several botanical extracts, including Rehmannia glutinosa, Ophiopogon japonicus, Scrophularia ningpoensis, Lonicera japonica, and Lophatherum gracile. In the context of TCM, it is used to clear heat, detoxify, and nourish yin, which translates to anti-inflammatory and mucosal-protective effects in clinical practice. It is commonly prescribed for recurrent aphthous ulcers, gingivitis, and periodontitis.

Brand names: Kou Yan Qing
Other names: Kouyanqing TabletsKou Yan Qing

Targets

MMP9 (Matrix metalloproteinase-9)HIF1A (Hypoxia-inducible factor 1-alpha)

Beyond the preview

Go deeper on kou yan qing tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on kou yan qing tablets.

Explore the full profile